Literature DB >> 24315317

Investigation of CYP2C19 allele and genotype frequencies in Iranian population using experimental and computational approaches.

Morteza Mahmoudi Saber1, Mohammadali Boroumand2, Mehrdad Behmanesh3.   

Abstract

CytochromeP4502C19 is a genetically polymorphic gene with prominent role in drug metabolism. Regarding its critical medical importance, this study was conducted to achieve accurate CYP2C19allele frequencies in Iranian population and hereby paving the way for a tailor-made CYP2C19 DNA test. Iran is a large multi-ethnic country, however, its population structure for CYP2C19 alleles is calculated as nearly zero (Fwc (st)=0.001). The Study was conducted on 691 individuals in Tehran, the conurbation in which total population structure is significantly eroded by massive immigration and DNA was analyzed by TaqMan SNP genotyping assay. A cumulative meta-analysis was then conducted to achieve less than five percent variation range in allele frequencies with 99.9% confidence level. High degree of Hardy-Weinberg equilibrium in pooled data proved the authenticity of meta-analysis. By cumulative meta-analysis the average frequencies of CYP2C19*2 and CYP2C19*3 alleles were calculated as 0.125[99.9% CI, 0.112-0.139] and 0.006[99.9% CI, 0.004-0.009], respectively. According to the solid frequency data obtained by pooling the data and meta-analysis and comparing with other ethnicities, Iranian population's CYP2C19 allele frequencies completely differ from other Asian ethnicities and matches African and European ethnicities the most. Since this is the biggest CYP2C19 allele frequency study in the Middle East, the results of this study will also be useful in cross-population and regional CYP2C19 genetic variation studies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CYP2C19; Cardiovascular diseases; Clopidogrel; Meta-analysis; Population structure; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24315317     DOI: 10.1016/j.thromres.2013.11.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Association of -77T>C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population.

Authors:  Saghar Pahlavanneshan; Amirhossein Ahmadi; Mohammadali Boroumand; Saeed Sadeghian; Mehrdad Behmanesh
Journal:  Iran J Basic Med Sci       Date:  2016-02       Impact factor: 2.699

2.  The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study.

Authors:  Younes Nozari; Sirous Vosooghi; Mohammadali Boroumand; Hamidreza Poorhosseini; Ebrahim Nematipour; Mojtaba Salarifar; Seyed Ebrahim Kassaian; Alireza Amirzadegan; Mohammad Alidoosti; Ali Mohammad Haji-Zeinali; Sepideh Saroukhani
Journal:  Anatol J Cardiol       Date:  2015-05       Impact factor: 1.596

3.  CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.

Authors:  Merve Arici; Gül Özhan
Journal:  Saudi Pharm J       Date:  2016-09-17       Impact factor: 4.330

4.  Frequency of M287T/AS3MT Single Nucleotide Polymorphism in an Iranian Population.

Authors:  Fatemeh Farhid; Fatemeh Nadali; Bahram Chahardouli; Saeed Mohammadi; Shahrbano Rostami; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-01-01

5.  The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review.

Authors:  Zainab Ali; Hazem Elewa
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.